ENSG:NGS-The Ensign Group Inc. (USD)

EQUITY | Medical Care Facilities | Nasdaq Global Select

Last Closing

USD 129.33

Change

0.00 (0.00)%

Market Cap

USD 1.10B

Volume

0.81M

Analyst Target

USD 62.50
Analyst Rating

Verdict

ducovest Verdict
Created with Highstock 5.0.6

Verdict

About

Ensign Group Inc offers skilled nursing & rehabilitative care services in Arizona, California, Colorado, Idaho, Iowa, Nebraska, Nevada, Oregon, Texas & Washington.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
ENSG QQQ
  • QQQ
Relative Returns (From:    To: 2025-04-05 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
OPCH Option Care Health Inc

-0.67 (-2.00%)

USD 5.52B
AMED Amedisys Inc

-0.19 (-0.21%)

USD 3.01B
SGRY Surgery Partners Inc

-0.60 (-2.84%)

USD 2.69B
LFST Lifestance Health Group Inc

-0.13 (-1.96%)

USD 2.67B
ACHC Acadia Healthcare Company Inc

-0.95 (-3.47%)

USD 2.54B
ADUS Addus HomeCare Corporation

-3.31 (-3.30%)

USD 1.82B
ASTH Astrana Health Inc

-0.78 (-2.59%)

USD 1.36B
AVAH Aveanna Healthcare Holdings In..

-0.07 (-1.39%)

USD 1.05B
HCSG Healthcare Services Group Inc

-0.17 (-1.69%)

USD 0.76B
CCRN Cross Country Healthcare Inc

-0.42 (-2.89%)

USD 0.48B

ETFs Containing ENSG

CBUSAS:SW Amundi S&P SmallCap 600 E.. 0.85 % 0.00 %

N/A

N/A
RTWO:LSE L&G Russell 2000 US Small.. 0.61 % 0.00 %

-1.89 (0.00%)

USD 0.19B
RTWP:LSE Legal & General UCITS ETF.. 0.61 % 0.00 %

-104.50 (0.00%)

USD 0.19B
IWO iShares Russell 2000 Grow.. 0.00 % 0.24 %

-1.52 (0.00%)

N/A
PTH Invesco DWA Healthcare Mo.. 0.00 % 0.60 %

-0.19 (0.00%)

USD 0.11B
JSMD Janus Henderson Small/Mid.. 0.00 % 0.50 %

-0.38 (0.00%)

USD 0.43B
OLD 0.00 % 0.50 %

N/A

N/A
OSCV Opus Small Cap Value Plus 0.00 % 0.79 %

-0.55 (0.00%)

USD 0.50B
KSCD 0.00 % 0.00 %

N/A

N/A
SLY 0.00 % 0.15 %

N/A

N/A
SLYG SPDR® S&P 600 Small Cap .. 0.00 % 0.15 %

-0.86 (0.00%)

N/A
VIOO Vanguard S&P Small-Cap 60.. 0.00 % 0.15 %

-1.10 (0.00%)

N/A
IDP6:LSE iShares S&P SmallCap 600 .. 0.00 % 0.00 %

-2.32 (0.00%)

N/A
IUS3:F iShares S&P Small Cap 600.. 0.00 % 0.00 %

-0.18 (0.00%)

N/A
ETLZ:XETRA L&G Russell 2000 US Small.. 0.00 % 0.00 %

-0.94 (0.00%)

USD 0.09B
IUS3:XETRA iShares S&P Small Cap 600.. 0.00 % 0.00 %

-0.84 (0.00%)

N/A
SMLE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.66% 66% D+ 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.66% 66% D+ 71% C-
Trailing 12 Months  
Capital Gain 8.03% 89% A- 79% B-
Dividend Return 0.20% 100% F 2% F
Total Return 8.23% 89% A- 77% C+
Trailing 5 Years  
Capital Gain 258.45% 82% B 92% A
Dividend Return 3.11% 50% F 5% F
Total Return 261.56% 82% B 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 23.31% 75% C 78% C+
Dividend Return 23.59% 75% C 78% C+
Total Return 0.28% 50% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 32.13% 57% F 56% F
Risk Adjusted Return 73.43% 100% F 89% A-
Market Capitalization 1.10B 100% F 91% A-

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 25.30 65% 36%
Price/Book Ratio 4.19 17% 27%
Price / Cash Flow Ratio 21.40 20% 13%
Price/Free Cash Flow Ratio 19.11 33% 18%
Management Effectiveness  
Return on Equity 17.88% 100% 88%
Return on Invested Capital 14.94% 80% 81%
Return on Assets 5.09% 78% 84%
Debt to Equity Ratio 7.71% 67% 73%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.